Cesarone MR, et al. Angiology 2002 Jan-Feb;53(1):1-6.
It is unclear whether aspirin is effective as DVT prophylaxis for high risk long-haul travellers. The lack of evidence should preclude it from being recommended.
Tag: aspirin
Feb 19 2016
Aspirin as DVT prophylaxis for high risk long-haul travellers
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1687
Feb 16 2011
Daily aspirin on long-term risk of death due to cancer
Rothwell PM, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377(9759): 31-41
Daily aspirin (≥ 75 mg) taken by participants in cardiovascular studies reduced the risk of cancer death.
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=723
Recent Comments